Consistent with our hypothesis, Acod1−/− mice exposed to a TLR7 agonist, a lupus relevant stimulus, displayed disruptions in the splenic architecture, increased serum anti-dsDNA and IL-6, higher kidney immune complex deposition and proteinuria, when compared to the WT IMQ-treated mice. Here, TLR7 is linked to systemic lupus erythematosus.